Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. to Report First Quarter 2019 Financial Results on May 9, 2019

WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”) today announced that it will release financial results for the first quarter of 2019 after the close of...
April 22, 2019 16:05 ET | Source: Avedro, Inc

Avedro to Present Research on Proprietary Corneal Cross-Linking Technologies at 2019 ARVO Annual Meeting

WALTHAM, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that three abstracts highlighting proprietary cross-linking technologies being developed by...
April 05, 2019 09:00 ET | Source: Avedro, Inc

UPDATE -- Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus

WALTHAM, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New...
April 05, 2019 07:00 ET | Source: Avedro, Inc

Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus

WALTHAM, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New...
March 21, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook

WALTHAM, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
March 13, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales

WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
February 28, 2019 16:05 ET | Source: Avedro, Inc

Avedro, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on March 21, 2019

WALTHAM, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
February 13, 2019 21:19 ET | Source: Avedro, Inc

Avedro Announces Pricing of Initial Public Offering

WALTHAM, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic...
February 04, 2019 08:13 ET | Source: Avedro, Inc

Avedro Launches Initial Public Offering

WALTHAM, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and...